Page last updated: 2024-08-20

perylene and Non-alcoholic Fatty Liver Disease

perylene has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bai, M; Bao, Y; Huang, Y; Li, Y; Liang, C; Liu, L; Song, Z; Sun, L; Wang, S; Yang, H; Yi, J; Yu, C1

Other Studies

1 other study(ies) available for perylene and Non-alcoholic Fatty Liver Disease

ArticleYear
Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo.
    Pharmacological research, 2020, Volume: 153

    Topics: AMP-Activated Protein Kinases; Animals; Anthracenes; Apoptosis; Cell Differentiation; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Male; Mesenchymal Stem Cells; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Perylene; Reactive Oxygen Species

2020